Cwm LLC Grows Holdings in Centene Corporation $CNC

Cwm LLC increased its position in shares of Centene Corporation (NYSE:CNC) by 132.5% during the 4th quarter, Holdings Channel reports. The firm owned 804,946 shares of the company’s stock after purchasing an additional 458,741 shares during the quarter. Cwm LLC’s holdings in Centene were worth $33,124,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Addison Advisors LLC boosted its holdings in Centene by 455.6% during the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after purchasing an additional 606 shares during the last quarter. Mowery & Schoenfeld Wealth Management LLC bought a new stake in Centene in the third quarter worth about $27,000. GoalVest Advisory LLC bought a new stake in shares of Centene in the fourth quarter valued at approximately $37,000. Union Bancaire Privee UBP SA bought a new stake in shares of Centene in the fourth quarter valued at approximately $37,000. Finally, WPG Advisers LLC raised its position in shares of Centene by 44.5% in the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after purchasing an additional 282 shares during the period. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CNC. Morgan Stanley boosted their price target on shares of Centene from $38.00 to $45.00 and gave the company an “equal weight” rating in a research report on Wednesday, March 4th. Mizuho set a $41.00 target price on shares of Centene and gave the stock a “neutral” rating in a report on Tuesday, March 10th. TD Cowen upped their target price on shares of Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a report on Wednesday, February 11th. Robert W. Baird upped their target price on shares of Centene from $36.00 to $37.00 and gave the stock a “neutral” rating in a report on Wednesday. Finally, Wall Street Zen lowered shares of Centene from a “buy” rating to a “hold” rating in a report on Sunday, February 15th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $41.88.

Centene Stock Performance

Centene stock opened at $38.88 on Friday. The firm’s 50 day simple moving average is $38.24 and its 200 day simple moving average is $38.98. The firm has a market capitalization of $19.12 billion, a PE ratio of -2.85, a price-to-earnings-growth ratio of 0.83 and a beta of 0.59. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $64.15. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.87.

Centene (NYSE:CNC) last issued its quarterly earnings results on Friday, February 6th. The company reported ($1.19) EPS for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. The firm had revenue of $49.73 billion for the quarter, compared to analyst estimates of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The business’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, analysts expect that Centene Corporation will post 6.86 earnings per share for the current fiscal year.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.